Can Aspirin Reduce the Risk of HCC in Cirrhosis: The AspiRe HCC Trial
Can Aspirin Reduce the Risk of HCC in Cirrhosis: The AspiRe HCC Trial
Not yet recruiting · NCT07529262 · Registry updated 2026-04-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Can Aspirin Reduce the Risk of HCC in Cirrhosis: The AspiRe HCC Trial | Digestive System Diseases, Fibrosis, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, carcinoma, cirrhosis of liver, epithelial neoplasm, liver disorder, neoplasm | Not yet recruiting | Phase 3 | 2026-04-14 | NCT07529262 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Curtin University | 13 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||